Swiss pharmaceutical giant Novartis has lost its patent infringement case against Sydney-based generics company Pharmacor over a top-selling heart medication.
The ATO has won the nod from the High Court to appeal a finding that a royalty withholding tax did not apply to payments from Schweppes to PepsiCo under agreements to sell brands like Pepsi and Gatorade in Australia.
Vittoria has defeated claims in an intellectual property battle that it infringed on rival Koninklijke Douwe Egbert’s trade mark for the design of its Moccona instant coffee jar.
NAB has successfully opposed a US company’s bid to register a trade mark for ‘UWallet’, with IP Australia rejecting claims the bank was trying to establish a “de facto monopoly”.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
Isuzu is not giving up its bid to slam the brakes on a suit by car alarm company Directed Electronics over alleged trade secrets theft.
A “time poor” judge’s extensive copying and pasting of submissions and an offensive tweet by senator Pauline Hanson were at the centre of the week’s biggest litigation wins.
In a loss for Bed Bath N’ Table, the Full Court has overturned a finding that homewares retailer House engaged in misleading and deceptive conduct by setting up its ‘Bed & Bath’ stores.
Cipla is opposing the extension of Novo Nordisk’s patent for its Victoza weight loss and diabetes drug, arguing extensions can only be granted for active ingredients and not entire formulations.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.